Immunome Inc. - Common Stock, $0.0001 par value per share (IMNM)

CUSIP: 45257U108

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
109,968,942
Total 13F shares
2,300,040
Share change
-13,640
Total reported value
$10,208,297
Price per share
$4.43
Number of holders
23
Value change
-$14,594
Number of buys
7
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 45257U108?
CUSIP 45257U108 identifies IMNM - Immunome Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Immunome Inc. - Common Stock, $0.0001 par value per share (IMNM) as of Q3 2022

As of 30 Sep 2022, Immunome Inc. - Common Stock, $0.0001 par value per share (IMNM) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,300,040 shares. The largest 10 holders included Prentice Capital Management, LP, Alpine Global Management, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Cerity Partners LLC, BlackRock Inc., STATE STREET CORP, ROYAL BANK OF CANADA, Magnus Financial Group LLC, and Baldwin Investment Management, LLC. This page lists 23 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.